The epidemiological situation in Kazakhstan on COVID-19, as well as around the world, remains unstable – new cases of the disease are registered daily, both among adults and among children. The only effective measure to combat the pandemic of coronovirus infection is mass immunization (vaccination) of the population of the whole world in order to create herd immunity and prevent further spread of the disease. In this regard, vaccination against coronavirus continues in Almaty and revaccination of citizens who were among the first to receive the vaccine 9 months ago has begun.
The Sputnik V vector vaccine, inactivated vaccines (QazCovid-in, Sinopharm, CoronaVac, Hayat-Vax), mRNA vaccine (Pfizer) and Chinese Vero Cell have been registered in Kazakhstan.
The vaccine from the American company Pfizer is now used only for immunization of adolescents, pregnant and lactating mothers.
Vaccination is a simple, safe and effective way to protect against diseases before a person comes into contact with their pathogens.
Indications for vaccination against coronavirus infection:
• People who did not have CVI (age 12 years and older).
• The age category of people over 60, because This category is seriously ill, with a high percentage of mortality.
• Persons who recovered from CVI 6 months after recovery. Vaccination is allowed 3 months after recovery.
Indications for immunization with the Komirnati vaccine (Phizer, USA):
• Children and teenagers from 12 to 18 years old
• Pregnant women from 16 to 37 weeks of pregnancy
• Lactating women 42 days after delivery and before the child reaches 2 years of age.
Contraindications for vaccination:
– Absolute contraindications – children under 12 years of age, as well as persons with a history of severe allergic reactions to vaccines.
– Relative contraindications – acute infectious and non-infectious diseases at the time of vaccination, exacerbation of any chronic diseases at the time of vaccination. This category of persons is vaccinated after complete recovery and after a medical examination.
Vaccination algorithm: before vaccination, the patient is examined by a doctor, signs an informed consent, after vaccination he is under observation for 30 minutes, and then for 3 days under the supervision of a doctor (on a call).
After 21 days, the patient receives the 2nd component of the vaccine, after which he is issued a vaccination passport within the electronic portal.
This is the introduction of an additional, reinforcing (booster) dose of the vaccine, in order to enhance the immune response.
Revaccination against CVI is subject to all persons who have received a complete completed course of primary vaccination against this infection.
Revaccination against CVI is carried out once, with an interval of 6 months after the completion of the primary vaccination course.
Persons who have been ill with CVI and who have previously received a full course of primary vaccination, revaccination is carried out no earlier than 6 months after recovery.
Revaccination against CVI is recommended with vaccine types that were not used in the primary vaccination course. That is, for those who received a vector vaccine, we recommend that you receive an inactivated vaccine (Vero Cell, QazVac). Those who received the inactivated vaccine can receive Sputnik V after 6 months.
Revaccination of pregnant women who have previously received the primary course of vaccination against CVI is carried out using the Komirnati vaccine (Phizer, USA) in the period from 16 to 37 weeks of pregnancy.